Soliris (eculizumab)

eculizumab · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Soliris (eculizumab), covering 2018-03-13 to 2018-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients [Phase 2]